¹«Á¦ ¹®¼­
 
   
¹«Á¦ ¹®¼­
 
 
 
 
 
³¯Â¥ 2010-12-02
Á¦¸ñ Generics bulletin Business newsletter for the generic medicines industry
³»¿ë Generics bulletin May 11 2007

Contents
Company News
Cipla rejects fine as formulations thrive
Adcock Ingram is availalable to purchase
Germany`s top firms work with major fund
US launches drive 19% rise at Sandoz
Glinmark shops as US turnover booms
Strides breaks off Accu-Break venture
Watson feels at ease with focusing on US
India`s Jubilant buys Hollister-Stier in US
PharmaRab may face huge fine or closure
Europe leads growth for Merck Generics
Wockhardt benefits from Pinewood deal

Market news
Regulators grasp INN gauntlet in Europe
FTC updates plan on aythorised generics
US Senate to debate law for biogenerics

Product news
Unipharm wins on alendronate patent
Court backs FDA on amlodipine approvals
Torrent lays claim to world`s first 'polypill'
Dr Reddy`s licenses a synthetic heparin

Features
DocMorris deal reflects changes in distribution
Celesio`s acquisition of mail-order
pharmacy DocMorris has put the spotlight
firmly on the anticipated changes in the way
medicines are distributed in Europe.
Deborah Wilkes looks at the prospects for
pharmacy chains

Regular
Events
Price Watch UK
People

°ü·ÃURL : http://www.generics-bulletin.com

 
 
 
   
¹«Á¦ ¹®¼­